Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Dec
6
2021
Prior Art Reporting Failure Does Not Provide Expectation of Success Foley & Lardner LLP
Dec
15
2021
Red Light – Green Light: CMS Vaccination Mandate is On Again in 26 States? Foley & Lardner LLP
Jan
14
2019
Michigan Brings Legalized Recreational Marijuana to the Midwest Foley & Lardner LLP
Apr
2
2019
Federal Circuit Finds Endo Method Of Treatment Claims Satisfy 35 USC 101 Foley & Lardner LLP
Aug
3
2022
FDA Allows Pharmacists to Prescribe the COVID-19 Antiviral Paxlovid Foley & Lardner LLP
Sep
28
2022
Developers Take Note: FDA Issues Clinical Decision Support Software Final Guidance Foley & Lardner LLP
Mar
1
2015
A Second Look At The Innovation Act Obviousness Type Double Patenting Statute Foley & Lardner LLP
Mar
15
2023
Personalized Medicine at FDA: The Scope & Significance of Progress in 2022 Foley & Lardner LLP
Apr
3
2023
FDA Publishes Framework for Digital Health Technologies in Clinical Trials Foley & Lardner LLP
Oct
16
2019
Personalized Cancer Therapy Found Nonobvious Foley & Lardner LLP
Oct
29
2019
USPTO October 2019 Patent Eligibility Guidance Update Includes New Example for Products of Nature Foley & Lardner LLP
May
16
2023
Federal Circuit Considers Patentability of Overlapping Ranges Foley & Lardner LLP
Jan
22
2020
Behavioral Health & Substance Abuse Services: Massachusetts Proposal Reflects Focus on Expanding Access and Coverage Foley & Lardner LLP
Mar
22
2016
Federal Circuit Finds Personal Jurisdiction Based On Plans To Market ANDA Product Foley & Lardner LLP
Mar
20
2020
Managing the Commercial Impact of Coronavirus: Emergency Order Relaxes Florida Licensure, Telehealth, and Practice Standards to Combat COVID-19 Foley & Lardner LLP
May
25
2016
Opportunities for Increased Drug Sales to Department of Veteran's Affairs Foley & Lardner LLP
Apr
7
2020
Personalized Medicine Coalition Releases Spring 2020 Newsletter Amid COVID-19 Foley & Lardner LLP
Feb
1
2024
Bringing A New Healthy Food Ingredient to Market: Understanding the Regulatory Pathways Foley & Lardner LLP
Dec
12
2016
Florida: No Telemedicine Exams for Medical Marijuana Foley & Lardner LLP
Aug
25
2020
Federal Circuit Upholds Tangentiality Exception To Prosecution History Estoppel Under Doctrine Of Equivalents Foley & Lardner LLP
Nov
2
2020
Skinny Label Doesn’t Prevent Infringement Liability Foley & Lardner LLP
Apr
11
2017
PTAB Not Bound By Prior Court Decisions Upholding Exelon Patents Foley & Lardner LLP
Jun
15
2017
Florida’s New Medical Marijuana Law: What Physicians and Entrepreneurs Need to Know Foley & Lardner LLP
Jul
17
2017
Impact of TC Heartland on ANDA and Biosimilar Litigation Foley & Lardner LLP
Feb
20
2018
Over 30% of New Drug Approvals in 2017 were Personalized Medicines Foley & Lardner LLP
Feb
1
2019
HHS Proposes New Rules To Eliminate Drug Rebates and Encourage Direct Discounts for Federal Beneficiaries Foley & Lardner LLP
Jun
18
2019
Why The TERM Act Is A Misguided Solution To A Different Problem Foley & Lardner LLP
Nov
14
2022
Colorado Legalizes Therapeutic Psychedelics – Now What? Foley & Lardner LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins